The Draft Screening Assessment for the Alkanolamines Group was published for a 60-day public comment period ending on September 16, 2020.

Pursuant to section 68 or 74 of the Canadian Environmental Protection Act, 1999 (CEPA) (Canada 1999), the Minister of the Environment and the Minister of Health have conducted a screening assessment of 11 substances referred to collectively under the Chemicals Management Plan as the Alkanolamines and Fatty Alkanolamides Group to determine whether they present or may present a risk to the environment or to human health. The substances in this group were identified as priorities for assessment as they met categorization criteria under subsection 73(1) of CEPA or were considered a priority on the basis of other human health concerns (ECCC, HC [modified 2017]). One additional substance was included in this assessment because it was determined to be a priority as a result of the approach described for Identification of Risk Assessment Priorities (IRAP).

The ecological risks of the substances in the Alkanolamines and Fatty Alkanolamides Group were characterized using the ecological risk classification (ERC) of organic substances (ECCC 2016a). The ERC describes the hazard of a substance using key metrics including mode of toxic action, chemical reactivity, food web-derived internal toxicity thresholds, bioavailability, and chemical and biological activity, and it considers the possible exposure of organisms in the aquatic and terrestrial environments on the basis of such factors as potential emission rates, overall persistence and long-range transport potential in air. The various lines of evidence are combined to identify substances as warranting further evaluation of their potential to cause harm to the environment or as having a low likelihood of causing harm to the environment.



Related News